Results 151 to 160 of about 259,609 (290)
Zuranolone: A case study in (regulatory) rush to judgement?
British Journal of Clinical Pharmacology, EarlyView.Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source
Selected legislation in the field of medical rescuers
, 2019 In the theoretical part, the problematics of work legislation of paramedics in the Czech Republic is described. The thesis summarises legislation concerning the acquisition and recognition of the qualifications of paramedics, paramedics for urgent ...
MAREŠOVÁ, Ivana
core
Developing medication independence: The experience of UK teenagers
British Journal of Clinical Pharmacology, EarlyView.Aims There is a progression through childhood from being provided medications by caregivers to having to take responsibility for medications yourself, but little is known about when the transition of adolescents managing medicines begins. The aim of this study was to obtain a cross‐sectional sample of UK adolescents and when they become independent ...
Holly Hutchins +5 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Aims We studied the prevalence of psychotropic use and psychotropic polypharmacy in persons with Parkinson's disease (PD) during a 10‐year follow‐up, because longitudinal studies on this topic are scarce although non‐motor symptoms of PD are often treated with psychotropics.
Noora Nieminen +4 more
wiley +1 more source
Decoding RNA regulation: Challenges and opportunities for RNA‐based therapies in Europe
British Journal of Clinical Pharmacology, EarlyView.Abstract RNA‐based medicinal products represent a promising frontier in personalised medicine, offering sequence‐specific disease targeting at various molecular levels, yet their clinical translation in the European Union (EU) may be hindered by regulatory uncertainty around definitions and evidence requirements; this study therefore aims to identify ...
Olivia C. Lewis +4 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aim We aimed to investigate whether genetic variation is associated with venous thromboembolism after immunization with SARS‐CoV‐2 vaccines. Methods We conducted a genome‐wide association study (GWAS) on cases of venous thromboembolism within 42 days after SARS‐CoV‐2 vaccination, recruited from reports of adverse drug reactions sent to the Swedish ...
Sofia Attelind +7 more
wiley +1 more source
Medical malpractice-Connecticut legislation-2004
, 2004 Electronic data.; Title from title screen.; "June 23, 2004."; Provides a summary of PA 04-155, An Act Concerning Medical Malpractice Insurance Reform, which the governor vetoed.; Harvested from the web on 7/8 ...
Coppolo, George.
core
British Journal of Clinical Pharmacology, EarlyView.Aims The Black Triangle Scheme, introduced in 2018 in Australia, does not appear to have increased the quantity of adverse drug event (ADE) reports. This study evaluated healthcare professionals' (HCPs') and consumers' awareness of the scheme, its influence on intentions for future ADE reporting, and suggested improvements.
Eyob Alemayehu Gebreyohannes +7 more
wiley +1 more source
, 1971 April 1971Summary of LegislationThis publication includes summaries of the legislation enacted by the 1971 Legislature. Not summarized are most appropriations bills; bills of a limited, local, technical, clarifying, or repealing nature; and bills that ...
Kansas Legislative Research Department
core
ECONOMIC AND MANAGERIAL APPROACH OF HEALTH INSURANCES
EIRP Proceedings, 2007 The paper represents an analysis in the domain of the social insurances for health care. It emphasizesthe necessity and the opportunity of creating in Romania a medical service market based on the competingsystem.
Georgeta Dragomir, Marinela Boboc
doaj